Analysis has shown that the infection control market is expected of reach in excess of USD €26.63bn by 2025.
The infection control market expected to reach $29bn (€26.63bn) by 2025 with a CAGR of 6.8% over the forecast period.
According to the infection control market report, government agencies are more and more involved in issuing rules to promote awareness pertaining to competent prevention actions all over the world, which is predicted to add to the growth of the market throughout the coming period.
Factors impacting growth
Aside from the COVID-19 crisis, the report highlights a number of different factors contributing to the growth of the market including a number of microorganisms such as fungi, viruses, and bacteria, which are the agents responsible for infections. These infections can be divided into different kinds comprising Hospital Acquired Infections (HAIs), intestinal and stomach infections, common childhood infections, eye infections, skin infections, ear infections, Sexually Transmitted Infections (STI/Ds), and lung and respiratory infections.
There are different steps for the prevention and control of such infections. For instance, the most effective method to stop the spread of HAIs in hospitals is handwashing, covering the mouth and nose while coughing and sneezing, using PPE such as masks and gloves.
Infection prevention
The report notes that the increasing number of government programmes to guarantee high-level infection prevention is assumed to be a noteworthy booster of the market, and that government agencies are more and more involved in issuing rules so as to promote awareness pertaining to competent prevention actions all over the world.
The report breaks down the market by regional analysis – North America, Europe, Asia-Pacific, and LAMEA (Latin America, Middle East, Africa). It shows that North America makes up for the biggest share of the infection control market due to the rising awareness of chronic infections together with the increasing number of service suppliers.
Europe and Asia Pacific
The infection control market in Europe is the second biggest market after the Asia Pacific. The Asia Pacific is predicted to show the quickest development all over the coming period due to the exceptional healthcare standards and infrastructure, increasing healthcare expenditure, and increasing attendance of outsourcing agencies all over this region.
